European ADRs rise on Wednesday as Credit Suisse and Barrick Gold gain

On Wednesday, US certificates of deposit of European stocks were trading up 0.3% at 1,170.44 on the ADR S & P / BNY Mellon Europe Select index.

In continental Europe, the winners were led by financial services firm Credit Suisse Group (CS) and COVID-19 vaccine developer BioNTech (BNTX), which rose 3.1% and 2.7% respectively. They are followed by Erytech Pharma (ERYP) and Trean Insurance Group (TIG), which are up 2.5% and 2.4%.

The main pullbacks on the continent were Zealand Pharma (ZEAL) and luxury e-commerce platform operator MYT Netherlands Parent (MYTE), which lost 3% and 2.8% respectively. They are followed by the hotel reservation site Trivago (TRVG) and the biotechnology Forward Pharma (FWP) which fell by 2.3% and 2.1%.

In the UK and Ireland, the winners were led by miner Barrick Gold (GOLD) and medical device maker EDAP TMS (EDAP), which rose 2.2% and 1.5% respectively. They were followed by biotech Verona Pharma (VRNA) and software maker Endava (DAVA), which gained 1.3% and 0.6%.

The biggest declines in the UK and Ireland were Mereo BioPharma (MREO) and mobile operator Vodafone (VOD), which lost 8.4% and 2.8% respectively. They were followed by biopharmaceutical company MorphoSys (MOR) and biotech Autolus Therapeutics (AUTL), which were down 2.6% and 2.4%.

You may also like

Comments are closed.